Perrigo Head Tightens Reins On Consumer Healthcare Sales, Marketing
This article was originally published in The Tan Sheet
Executive Summary
Perrigo has moved its Consumer Healthcare head to direct global operations for OTC and Rx products while President and CEO Joseph Papa will have the firm's consumer products sales and marketing staff report directly to him
|
Perrigo has moved its Consumer Healthcare head to direct global operations for OTC and Rx products while President and CEO Joseph Papa will have the firm's consumer products sales and marketing staff report directly to him. The changes move John Hendrickson from executive vice president and general manager of the firm's consumer products division to executive VP for global operations and supply chain, the Allegan, Mich.-based private retailer said March 27. Perrigo spokesman Arthur J. Shannon told "The Tan Sheet" the moves are part of Papa's plan to integrate the company's operations on a global basis. Consumer Healthcare's operations and supply chain elements will report to Hendrickson, he said. "The operations side of our business is an area where we really want to focus, and John has tremendous background in that side," Shannon said. "He started out as a chemical engineer and has been around operations his entire career." Hendrickson also is the Consumer Healthcare Products Association chairman. He was re-elected for a second one-year term at CHPA's executive conference March 16 (1 'The Tan Sheet,' March 26, 2007, In Brief). Papa's experience in the industry figured prominently in his decision to have Consumer Healthcare sales and marketing report to him, Shannon said. "Joe wanted to really fully integrate the company, so it's global operations - as opposed to just Consumer Healthcare operations - in the sales and marketing side," he said. "Joe has been in the business for 24 years and has been in the sales and marketing side for a good majority of that." "He felt very comfortable having those guys report to him and having John focus on global operations," Shannon added. During Perrigo's latest quarter, $19.5 million in new consumer product sales drove Consumer Healthcare's 2 percent sales growth to $275.9 million, despite an acetaminophen recall and slower-than-expected cough/cold medicine sales (2 (Also see "Perrigo Foresees 2008 Omeprazole Launch; New Products Offset Sales Woes" - Pink Sheet, 5 Feb, 2007.), p. 5). - Malcolm Spicer ([email protected]) |